Building a consumer health brand?
We run PR for companies in this market: from category launches and funding announcements to regulatory communications and the press cycle that comes with selling directly to consumers, employers or insurers.
At-home hormone & fertility diagnostic testing
Hertility Health sells direct-to-consumer at-home hormone and fertility blood tests paired with clinician-reviewed reports on reproductive health.
The read
Hertility Health, founded by reproductive scientist Dr Helen O'Neill, sells at-home hormone-testing kits that screen for fertility decline, PCOS, endometriosis and menopause onset, paired with clinician-reviewed reports. Its 2026 Reproductive Report, drawn from over 600,000 assessments, claimed the service cuts typical diagnosis timelines for some conditions from years to days.
The company has raised roughly $14m to date, including a widely publicised community funding round and a disclosed backing from actress Emma Watson.
The Bridgehead view
Hertility sits closer to a regulated diagnostics business than a lifestyle app — its CQC registration is the point of difference and the point of friction, since it must justify direct-to-consumer testing against a backdrop of NHS gatekeeping it's explicitly trying to bypass.
Work with us
We run PR for companies in this market: from category launches and funding announcements to regulatory communications and the press cycle that comes with selling directly to consumers, employers or insurers.
We advise insurers, employers and benefits providers on reputation, policy engagement and communications that understand the sector.
Related platforms
Flo is an AI-powered cycle, fertility and pregnancy tracking app used by millions of women worldwide to log symptoms and predict ovulation and periods.
ReadClue, made by Berlin's Biowink GmbH, is a science-backed period and cycle tracking app used in 180 countries.
ReadThe firm that knows health-tech
Whether you build consumer health technology or work across the insurers, employers and providers who buy it, we know the market, the media and the regulatory landscape it operates in. Thirty minutes with a partner tells you if we can help.